Improving treatment for liver tumors using advanced ultrasound techniques
Developing an Accurate and Robust Targeting Technique to Enable Transcostal Histotripsy Treatment of Liver Tumors
This study is exploring a new way to treat liver tumors using focused ultrasound to target the tumors more precisely, which could offer a safer, noninvasive option for patients with liver cancer.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11083552 on NIH RePORTER |
What this research studies
This research aims to enhance the treatment of liver tumors by developing a new method that allows for better targeting of tumors using ultrasound. The approach involves using focused ultrasound pulses to create cavitation, which disrupts tumor tissue without harming surrounding areas. By integrating advanced imaging techniques, this project seeks to overcome current limitations that prevent many liver tumors from being treated effectively. Patients may benefit from a noninvasive treatment option that could improve outcomes for those with liver cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with liver tumors, particularly those that are currently difficult to visualize and treat due to their location.
Not a fit: Patients with liver tumors that are easily accessible and can be treated with existing methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and less invasive treatment option for patients with liver tumors.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for tumor treatment, but this specific approach is novel and aims to address significant limitations in current methods.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Falk, Katrina Lauren — University of Wisconsin-Madison
- Study coordinator: Falk, Katrina Lauren
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.